menu search

cardinal health to webcast discussion of third-quarter results for fiscal year 2022 on may 5

DUBLIN, Ohio , April 1, 2022 /PRNewswire/ -- cardinal Health (NYSE: CAH) plans to release third-quarter...

April 1, 2022, 6:55 am

cardinal health (cah) to extend medical distribution presence

cardinal Health's (CAH) plans to build a new facility in Columbus, OH, can expand its medical distribut...

March 31, 2022, 12:02 pm

Biocardia, inc. (bcda) ceo peter altman on q4 2021 results - earnings call transcript

Biocardia, Inc. (BCDA) CEO Peter Altman on Q4 2021 Results - Earnings Call Transcript...

March 29, 2022, 7:53 pm

cardiol therapeutics looks ahead to busy 2022 as it advances new treatment options for cardiovascular disease

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc CEO David Elsley told investors that the clinical-stag...

March 24, 2022, 10:04 am

cardinal health remains a bargain

cardinal Health Remains A Bargain...

March 23, 2022, 5:26 pm

cardinal health (cah) unveils the first surgical incise drape

cardinal Health's (CAH) introduction of the first surgical incise drape is likely to lower SSIs....

March 21, 2022, 1:33 pm

Here's why you should retain cardinal health (cah) stock now

cardinal Health (CAH) continues to gain traction from the solid pharmaceutical segment and a diversifie...

March 15, 2022, 12:48 pm

Cincor pharma to report fourth quarter and full year 2021 financial results and host conference call on march 22, 2022

BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC), a clinical-stage biopharmaceutical company focused on developing its le...

March 15, 2022, 9:41 am

cardiol therapeutics says jennifer m. chao has been appointed as director of the company

cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc has announced that Jennifer M. Chao has been appointed...

March 15, 2022, 8:16 am

Should value investors pick cardinal health (cah) stock now?

Let's see if cardinal Health (CAH) stock is a good choice for value-oriented investors right now from m...

March 15, 2022, 3:01 am

cardiovascular systems' (csii) low procedure volume dents sales

cardiovascular Systems (CSII) notes that recovery from the Delta variant has been suppressed by the eme...

March 14, 2022, 1:32 pm

Cleanse your portfolio by discarding these 4 toxic stocks

Protect your portfolio's health by dumping toxic stocks like Madison Square (MSGE), TripAdvisor (TRIP), Shift4 Payments (FOUR) and Cano Health (CANO)....

March 14, 2022, 9:02 am

Acutus medical to announce fourth quarter and full-year financial results

CARLSBAD, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on i...

March 10, 2022, 4:01 pm

Windtree to present at oppenheimer's 32nd annual healthcare conference

WARRINGTON, Pa., March 10, 2022 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused o...

March 10, 2022, 8:00 am

Planet to participate in panels at upcoming conferences

SAN FRANCISCO--(BUSINESS WIRE)--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, today announced that members of...

March 2, 2022, 9:00 am

Planet to participate in panels at upcoming conferences

SAN FRANCISCO--(BUSINESS WIRE)--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, today announced that members of...

March 2, 2022, 9:00 am

Planet to participate in panels at upcoming conferences

SAN FRANCISCO--(BUSINESS WIRE)--Planet Labs PBC (NYSE: PL), a leading provider of daily data and insights about Earth, today announced that members of...

March 2, 2022, 9:00 am

cardiff: a long-term biotech to own based on overcoming cancer resistance

cardiff has done well in a Phase 2 study using onvansertib + FOLFIRI + Avastin in treating KRAS-mutated...

March 1, 2022, 4:57 pm

cardiff: a long-term biotech to own based on overcoming cancer resistance

cardiff has done well in a Phase 2 study using onvansertib + FOLFIRI + Avastin in treating KRAS-mutated...

March 1, 2022, 4:57 pm

cardiff: a long-term biotech to own based on overcoming cancer resistance

cardiff has done well in a Phase 2 study using onvansertib + FOLFIRI + Avastin in treating KRAS-mutated...

March 1, 2022, 4:57 pm


Search within

Pages Search Results: